Skip to main content

Second shareholder asks Brenntag to split

16th February 2023

Submitted by:

Andrew Warmington

Engine Capital, an investment firm with a 1% stake in Brenntag, has become the second to advise the company to separate out its two businesses. PrimeStone, which owns 2%, had urged similar action in December, when Brenntag itself was in discussions with Univar Solutions about a possible merger.

In an open letter to the supervisory board, Engine managing partners Arnaud Ajdler and Brad Favreau said that the state of the market and the firm’s “its strong supplier relationships, attractive and growing end markets, the latent and unrealised value of the Specialties business” give it many opportunities to increase shareholder value. However, it is not currently “achieving its full potential”.

Separating out certain aspects of Brenntag Specialties from Brenntag Essentials was a step in the right direction, but Engine believes that Brenntag Specialties “will continue to lag its peers and will be unable to optimise its operating performance” as part of Brenntag and its shares will not match those of other pure-play speciality firms because of the ‘conglomerate discount’ investors assign to Brenntag.

A full split, Engine argued, will enable Brenntag Specialties to achieve its full potential as a stand-alone entity and help unlock long-term value. As it stands, the division’s organic growth of 26.4% over the past 21 months has lagged behind those of pure-play speciality distributors Azelis (37.6%) and IMCD (39.9%). To address these issues and enhance long-term shareholder value, Engine asked the board to:

* Publicly commit to prioritising a separation and provide a timeline for it

* Establish a meaningful share repurchase programme to take advantage of the current undervaluation and the 1.3x debt-to-EBITDA ratio

* Add a shareholder representative with relevant capital allocation, investing and valuation analysis experience to the supervisory board

Engine cited the “surprising and unfortunate” move on Univar, which led to a 17.7% fall in the share price over three weeks. Although it was soon abandoned, “the mere fact that these conversations took place indicates that leadership was ready to consider a transformational and risky transaction just weeks after specifically outlining plans to focus on small tuck-in acquisitions during its November 2022 Capital Markets Day”. B

ecause the market approaches needed in speciality chemical distribution are different to those in commodities and require a different skill set in sales. “The feedback we received from numerous industry sources is that specialties salespeople are more attracted to pure-play distributors like Azelis or IMCD, rather than Brenntag, which is perceived as having less of a specialties DNA,” Engine concluded.

In addition, because Brenntag is not seen as a specialities distributor, there have been numerous instances where owners of speciality chemical distributors were simply not interested in selling to Brenntag, despite Brenntag Specialties operating more independently. Likewise, many chemical manufacturers prefer pure-play speciality distributors.

For all these reasons, Engine concluded, it believes that Brenntag would trade at approximately €140/share by the end of 2024, double the current share price, with a spin-off. They asked for the board to meet with them to discuss these issues.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Halozyme has dropped its approach to buy Evotec

Halozyme abandons Evotec bid

San Diego-based biopharmaceutical company Halozyme Therapeutics has withdrawn the offer it made for Evotec after

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington